NEWS
No chill pill for Pfizer over PBS as row erupts
CANBERRA: Multinational conglomerate Pfizer has accused the Pharmaceutical Benefits Scheme of “undervaluing” medical products in… read more
First sales data fires up shares in Mesoblast Group
MELBOURNE: Biotech Mesoblast has reported strong initial sales of its cell therapy, Ryoncil, its first… read more
Women’s shed finally opens as sector ponders its future
MELBOURNE: Men’s sheds now outnumber McDonald’s restaurants. While the fast food giant has about 1,000… read more
